Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma

BACKGROUND: we have recently shown that Tel-eVax, a genetic vaccine targeting dog telomerase (dTERT) and based on Adenovirus (Ad)/DNA Electro-Gene-Transfer (DNA–EGT) technology can induce strong immune response and increase overall survival (OS) of dogs affected by multicentric Diffuse Large B cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Impellizeri, Joseph A., Gavazza, Alessandra, Greissworth, Eliana, Crispo, Anna, Montella, Maurizio, Ciliberto, Gennaro, Lubas, George, Aurisicchio, Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290499/
https://ncbi.nlm.nih.gov/pubmed/30537967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1738-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados